Related Experiment Video
Updated: Jul 19, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy
N Muge Kuyumcu-Martinez1, Thomas A Cooper
1Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
Myotonic dystrophy (DM), the most common form of adult onset muscular dystrophy, affects skeletal muscle, heart, and the central nervous system (CNS). Mortality results primarily from muscle wasting and cardiac arrhythmias. There are two forms of the disease: DM1 and DM2. DM1, which constitutes 98% of cases, is caused by a CTG expansion in the 3' untranslated region (UTR) of the DMPK gene. DM2 is caused by a CCTG expansion in the first intron of the ZNF9 gene. RNA containing CUG- or CCUG-expanded repeats are transcribed but are retained in the nucleus in foci. Disease pathogenesis results primarily from a gain of function of the expanded RNAs, which alter developmentally regulated alternative splicing as well as pathways of muscle differentiation. The toxic RNA has been implicated in sequestration of splicing regulators and transcription factors thereby causing specific symptoms of the disease. Here we review the proposed mechanisms for the toxic effects of the expanded repeats and discuss the molecular mechanisms of splicing misregulation and disease pathogenesis.
Insights
Myotonic dystrophy (DM) is caused by expanded RNA repeats in specific genes, leading to toxic effects on RNA splicing and muscle cell function. This review explores the molecular mechanisms behind these toxic effects and disease development.
Area of Science:
- Genetics and Molecular Biology
- Neuromuscular Disorders
- RNA Biology
Background:
- Myotonic dystrophy (DM) is the most common adult-onset muscular dystrophy, impacting skeletal muscle, heart, and CNS.
- Mortality in DM is primarily due to muscle wasting and cardiac arrhythmias.
- DM presents in two forms: DM1 (CTG expansion in DMPK gene) and DM2 (CCTG expansion in ZNF9 gene).
Purpose of the Study:
- To review proposed mechanisms for the toxic effects of expanded RNA repeats in DM.
- To discuss the molecular mechanisms of splicing misregulation in DM pathogenesis.
- To explore how toxic RNA impacts muscle differentiation and CNS function.
Main Methods:
- Review of existing literature on DM pathogenesis.
- Analysis of molecular mechanisms involving expanded RNA repeats.
- Examination of RNA retention in nuclear foci and its consequences.
Main Results:
- Expanded RNA repeats are transcribed but retained in nuclear foci.
- Disease pathogenesis involves a gain of function of expanded RNAs.
- Toxic RNA sequesters splicing regulators and transcription factors, disrupting alternative splicing and muscle differentiation.
Conclusions:
- Expanded RNA repeats are the primary drivers of DM pathogenesis.
- Splicing misregulation and altered muscle differentiation pathways are key molecular events.
- Understanding these mechanisms is crucial for developing targeted therapies for myotonic dystrophy.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
Satellite Stem Cells and Muscular Dystrophy
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

